BACKGROUND: The aim of this study is to determine the effect of the implementation and evolution of a multidisciplinary esophagectomy care pathway on postoperative outcomes over a 20-year experience. STUDY DESIGN: All patients undergoing esophagectomy for cancer between 1991 and 2012 were included. Patients were divided into four groups (Gp1 1991-1996, Gp2 1997-2002, Gp3 2003-2007, and Gp4 2008-2012). RESULTS: Five hundred and ninety-five patients were included (Gp1 92, Gp2 159, Gp3 161, and Gp4 183). Age remained consistent over time; however, a progressive significant increase was observed in BMI and Charlson comorbidity index. Increases were also noted in patients with clinical stage III cancers, in the use of neoadjuvant chemoradiotherapy, in salvage esophagectomy and in the utilization of pretreatment jejunostomy. We observed a significant reduction in estimated blood loss (EBL) and operative room IV fluid administration (ORFA) during the study period. Median ICU stay and length of hospital stay (LOS) (10 (5-50) to 8 (5-115) days) decreased over time. In-hospital mortality (0.3 %) and postoperative complications remained consistent over time. cumulative sum (CUSUM) analysis showed that EBL, ORFA, and LOS all declined during the study period, reaching mean values at case 120, 310, and 175, respectively. CONCLUSIONS: The results of this study show that process improvement within the pathway is likely more significant than the level of comorbidities, application of neoadjuvant chemoradiation, or technical approach in patients undergoing esophagectomy.
BACKGROUND: The aim of this study is to determine the effect of the implementation and evolution of a multidisciplinary esophagectomy care pathway on postoperative outcomes over a 20-year experience. STUDY DESIGN: All patients undergoing esophagectomy for cancer between 1991 and 2012 were included. Patients were divided into four groups (Gp1 1991-1996, Gp2 1997-2002, Gp3 2003-2007, and Gp4 2008-2012). RESULTS: Five hundred and ninety-five patients were included (Gp1 92, Gp2 159, Gp3 161, and Gp4 183). Age remained consistent over time; however, a progressive significant increase was observed in BMI and Charlson comorbidity index. Increases were also noted in patients with clinical stage III cancers, in the use of neoadjuvant chemoradiotherapy, in salvage esophagectomy and in the utilization of pretreatment jejunostomy. We observed a significant reduction in estimated blood loss (EBL) and operative room IV fluid administration (ORFA) during the study period. Median ICU stay and length of hospital stay (LOS) (10 (5-50) to 8 (5-115) days) decreased over time. In-hospital mortality (0.3 %) and postoperative complications remained consistent over time. cumulative sum (CUSUM) analysis showed that EBL, ORFA, and LOS all declined during the study period, reaching mean values at case 120, 310, and 175, respectively. CONCLUSIONS: The results of this study show that process improvement within the pathway is likely more significant than the level of comorbidities, application of neoadjuvant chemoradiation, or technical approach in patients undergoing esophagectomy.
Authors: Geoffrey Paul Kohn; Joseph Anton Galanko; Michael Owen Meyers; Richard Harry Feins; Timothy Michael Farrell Journal: J Gastrointest Surg Date: 2009-09-16 Impact factor: 3.452
Authors: U O Gustafsson; M J Scott; W Schwenk; N Demartines; D Roulin; N Francis; C E McNaught; J Macfie; A S Liberman; M Soop; A Hill; R H Kennedy; D N Lobo; K Fearon; O Ljungqvist Journal: World J Surg Date: 2013-02 Impact factor: 3.352
Authors: Nicolas C Buchs; François Pugin; Pascal Bucher; Monika E Hagen; Gilles Chassot; Pascale Koutny-Fong; Philippe Morel Journal: Surg Endosc Date: 2011-11-02 Impact factor: 4.584
Authors: Oliver S Eng; Renee L Arlow; Dirk Moore; Chunxia Chen; John E Langenfeld; David A August; Darren R Carpizo Journal: J Surg Res Date: 2015-07-16 Impact factor: 2.192
Authors: James P Dolan; Patrick J McLaren; Brian S Diggs; Paul H Schipper; Brandon H Tieu; Brett C Sheppard; Erin W Gilbert; Molly A Conroy; John G Hunter Journal: J Laparoendosc Adv Surg Tech A Date: 2017-05-09 Impact factor: 1.878
Authors: Katia Noyes; John R T Monson; Irfan Rizvi; Ann Savastano; James S A Green; Nick Sevdalis Journal: J Oncol Pract Date: 2016-09-30 Impact factor: 3.840
Authors: Henner M Schmidt; Kamran Mohiuddin; Artur M Bodnar; Mustapha El Lakis; Stephen Kaplan; Shayan Irani; Ian Gan; Andrew Ross; Donald E Low Journal: Surg Endosc Date: 2015-11-05 Impact factor: 4.584
Authors: C Mallmann; H Drinhaus; H Fuchs; L M Schiffmann; C Cleff; E Schönau; C J Bruns; T Annecke; W Schröder Journal: Chirurg Date: 2021-02 Impact factor: 0.955